Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
18.02.26
/
50%
€84.50
Target price
18.02.27
-
Performance (%)
-11.24%
Price
17.04.26
€75.00
Summary
This prediction is currently active. The prediction for Rhythm Pharmaceuticals disappoints with a performance of -11.24%. This prediction currently runs until 18.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 4.895% | 4.895% |
| iShares Core DAX® | 3.593% | 6.427% |
| iShares Nasdaq 100 | 5.810% | 6.381% |
| iShares Nikkei 225® | 4.075% | 9.307% |
| iShares S&P 500 | 4.142% | 4.938% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€113.07
17.03.27
17.03.27
-2.58%
17.04.26
17.04.26
